Why the study?
To estimate the prevalence of HCM in neonates born to diabetic mothers, evaluate therapeutic interventions, and assess its association with maternal diabetes type.
What is the prevalence of hypertrophic cardiomyopathy in neonates of diabetic mothers, and is it associated with maternal diabetes control or type?
What is the prevalence of hypertrophic cardiomyopathy in neonates of diabetic mothers, and is it associated with maternal diabetes control or type?
Uncontrolled maternal diabetes is significantly associated with a 14% prevalence of hypertrophic cardiomyopathy in neonates, which can be effectively managed with propranolol.
No takes yet. Share an insight, caveat, or question.
Neonatal HCM screening in diabetic pregnancies remains hypothesis-generating; leaves open optimal detection and maternal diabetes-type associations.
Lookzadeh et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: